Predicting progression of Alzheimer's disease

[1]  W. Chan,et al.  Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease , 2009, Alzheimers Res Ther.

[2]  A. Atri,et al.  Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease , 2008, Alzheimer disease and associated disorders.

[3]  R. Doody.  We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer’s disease drug development , 2008, Alzheimer's & Dementia.

[4]  W. Chan,et al.  Importance of Subtle Amnestic and Nonamnestic Deficits in Mild Cognitive Impairment: Prognosis and Conversion to Dementia , 2007, Dementia and Geriatric Cognitive Disorders.

[5]  R. Doody,et al.  Influence of Premorbid IQ and Education on Progression of Alzheimer’s Disease , 2006, Dementia and Geriatric Cognitive Disorders.

[6]  W. Chan,et al.  Changing Patient Characteristics and Survival Experience in an Alzheimer’s Center Patient Cohort , 2005, Dementia and Geriatric Cognitive Disorders.

[7]  M. Kataki,et al.  A Method for Estimating Duration of Illness in Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[8]  R. Doody,et al.  A method for estimating progression rates in Alzheimer disease. , 2001, Archives of neurology.

[9]  A. Heyman,et al.  Consortium to establish a registry for Alzheimer's disease: development, database structure, and selected findings. , 1997, Topics in health information management.

[10]  R. Doody,et al.  The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study , 1997, Neurology.

[11]  P. Rabins.  Predicting progression of Alzheimer disease. , 1997, Journal of the American Medical Association (JAMA).

[12]  M. Albert,et al.  Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease , 1994, Neurology.

[13]  L. Schneider,et al.  Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. , 1994, Archives of neurology.

[14]  M. Folstein,et al.  Population-based norms for the Mini-Mental State Examination by age and educational level. , 1993, JAMA.

[15]  M. Sliwinski,et al.  Development and validation of a model for estimating premorbid verbal intelligence in the elderly. , 1991, Journal of clinical and experimental neuropsychology.

[16]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[17]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[18]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[19]  H. Nelson,et al.  Dementia: The Estimation of Premorbid Intelligence Levels Using the New Adult Reading Test , 1978, Cortex.

[20]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[21]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[22]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[23]  T. Golde.  Alzheimer's Research & Therapy , 2009 .

[24]  R. Mahurin,et al.  Verbal series attention test: Clinical utility in the assessment of dementia , 1996 .